Table 3. Comparison Among Patient-Reported Outcome Measures for HHT-Associated Epistaxis.
| Epistaxis PROM | Content validity | Internal consistency | Validity | Test-retest reliability | Responsiveness | MCID | |
|---|---|---|---|---|---|---|---|
| Concurrent | Discriminant | ||||||
| NOSE HHT | +a | + | + | + | + | + | + |
| ESS | + | 0 | + | 0 | 0 | 0 | − |
| EQQol | + | + | + | 0 | + | + | 0 |
Abbreviations: ESS, Epistaxis Severity Score; EQQol, Epistaxis Questionnaire Quality of Life; HHT, hereditary hemorrhagic telangiectasia; MCID, minimal clinically important difference; NOSE, Nasal Outcome Score for Epistaxis; PROM, patient-reported outcome measure.
+ indicates completed adequately; − indicates completed but inadequate; 0 indicates not completed.